Utah Medical Products Inc
UTMD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000706698
No open-market purchases or sales by Utah Medical Products Inc insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $159.9M in total; no superinvestor holds it.
Holders of 5% or more of UTMD
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Utah Medical Products Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Brandes Investment Partners, LP | 13G/A | 10.40%333.2K shares | +2.00 ppfrom 8.40% | May 14, 20253 filings | Sep 5, 2025 | SEC |
| Renaissance Technologies LLC | 13G/A | 6.70%230.6K shares | – | Nov 13, 20241 filing | Nov 13, 2024 | SEC |
| Dimensional Fund Advisors LP | 13G/A | 6.10%197.5K shares | – | Jul 15, 20251 filing | Jul 15, 2025 | SEC |
| BlackRock, Inc. | 13G | 5.30%172.7K shares | +0.33 ppfrom 4.97% | Feb 5, 20252 filings | Jul 17, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on Utah Medical Products Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 27, 20261:53 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Sep 5, 20254:59 PM ET | Brandes Investment Partners, LP | 13G/A | 10.40%333.2K shares | +2.00 ppfrom 8.40% | Aug 31, 2025 | SEC |
| Aug 12, 20254:29 PM ET | Brandes Investment Partners, LP | 13G/A | 8.40%271.5K shares | +1.00 ppfrom 7.40% | Jun 30, 2025 | SEC |
| Jul 17, 20258:12 PM ET | BlackRock, Inc. | 13G | 5.30%172.7K shares | +0.33 ppfrom 4.97% | Jun 30, 2025 | SEC |
| Jul 15, 20254:03 PM ET | Dimensional Fund Advisors LP | 13G/A | 6.10%197.5K shares | – | Jun 30, 2025 | SEC |
| May 14, 20255:09 PM ET | Brandes Investment Partners, LP | 13G | 7.40%242.4K shares | New | Mar 31, 2025 | SEC |
| Feb 5, 20251:23 PM ET | BlackRock, Inc. | 13G/A | 4.97%168.6K shares | –Below 5% | Dec 31, 2024 | SEC |
| Jan 8, 20259:54 AM ET | FMR LLCand 1 other | 13G/A | 2.70%92.4K shares | –Below 5% | Dec 31, 2024 | SEC |
| Nov 13, 20243:57 PM ET | Renaissance Technologies LLCand 1 other | 13G/A | 6.70%230.6K shares | – | Sep 30, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Utah Medical Products Inc shares.
No Form 144 notices for Utah Medical Products Inc are on file.